Psychological and behavioural impact of returning personal results from whole-genome sequencing: the HealthSeq project

Saskia C. Sanderson, Michael D. Linderman, Sabrina A. Suckiel, Randi Zinberg, Melissa P. Wasserstein, Andrew Kasarskis, George A. Diaz, Eric E. Schadt

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Providing ostensibly healthy individuals with personal results from whole-genome sequencing could lead to improved health and well-being via enhanced disease risk prediction, prevention, and diagnosis, but also poses practical and ethical challenges. Understanding how individuals react psychologically and behaviourally will be key in assessing the potential utility of personal whole-genome sequencing. We conducted an exploratory longitudinal cohort study in which quantitative surveys and in-depth qualitative interviews were conducted before and after personal results were returned to individuals who underwent whole-genome sequencing. The participants were offered a range of interpreted results, including Alzheimer’s disease, type 2 diabetes, pharmacogenomics, rare disease-associated variants, and ancestry. They were also offered their raw data. Of the 35 participants at baseline, 29 (82.9%) completed the 6-month follow-up. In the quantitative surveys, test-related distress was low, although it was higher at 1-week than 6-month follow-up (Z=2.68, P=0.007). In the 6-month qualitative interviews, most participants felt happy or relieved about their results. A few were concerned, particularly about rare disease-associated variants and Alzheimer’s disease results. Two of the 29 participants had sought clinical follow-up as a direct or indirect consequence of rare disease-associated variants results. Several had mentioned their results to their doctors. Some participants felt having their raw data might be medically useful to them in the future. The majority reported positive reactions to having their genomes sequenced, but there were notable exceptions to this. The impact and value of returning personal results from whole-genome sequencing when implemented on a larger scale remains to be seen.European Journal of Human Genetics advance online publication, 4 January 2017; doi:10.1038/ejhg.2016.178.

Original languageEnglish (US)
JournalEuropean Journal of Human Genetics
DOIs
StateAccepted/In press - Jan 4 2017

Fingerprint

Genome
Psychology
Rare Diseases
Interviews
Pharmacogenetics
Medical Genetics
Type 2 Diabetes Mellitus
Longitudinal Studies
Publications
Alzheimer Disease
Cohort Studies
Health
Surveys and Questionnaires

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Psychological and behavioural impact of returning personal results from whole-genome sequencing : the HealthSeq project. / Sanderson, Saskia C.; Linderman, Michael D.; Suckiel, Sabrina A.; Zinberg, Randi; Wasserstein, Melissa P.; Kasarskis, Andrew; Diaz, George A.; Schadt, Eric E.

In: European Journal of Human Genetics, 04.01.2017.

Research output: Contribution to journalArticle

Sanderson, Saskia C. ; Linderman, Michael D. ; Suckiel, Sabrina A. ; Zinberg, Randi ; Wasserstein, Melissa P. ; Kasarskis, Andrew ; Diaz, George A. ; Schadt, Eric E. / Psychological and behavioural impact of returning personal results from whole-genome sequencing : the HealthSeq project. In: European Journal of Human Genetics. 2017.
@article{ab518002b96b4bb480d3670e8717fab9,
title = "Psychological and behavioural impact of returning personal results from whole-genome sequencing: the HealthSeq project",
abstract = "Providing ostensibly healthy individuals with personal results from whole-genome sequencing could lead to improved health and well-being via enhanced disease risk prediction, prevention, and diagnosis, but also poses practical and ethical challenges. Understanding how individuals react psychologically and behaviourally will be key in assessing the potential utility of personal whole-genome sequencing. We conducted an exploratory longitudinal cohort study in which quantitative surveys and in-depth qualitative interviews were conducted before and after personal results were returned to individuals who underwent whole-genome sequencing. The participants were offered a range of interpreted results, including Alzheimer’s disease, type 2 diabetes, pharmacogenomics, rare disease-associated variants, and ancestry. They were also offered their raw data. Of the 35 participants at baseline, 29 (82.9{\%}) completed the 6-month follow-up. In the quantitative surveys, test-related distress was low, although it was higher at 1-week than 6-month follow-up (Z=2.68, P=0.007). In the 6-month qualitative interviews, most participants felt happy or relieved about their results. A few were concerned, particularly about rare disease-associated variants and Alzheimer’s disease results. Two of the 29 participants had sought clinical follow-up as a direct or indirect consequence of rare disease-associated variants results. Several had mentioned their results to their doctors. Some participants felt having their raw data might be medically useful to them in the future. The majority reported positive reactions to having their genomes sequenced, but there were notable exceptions to this. The impact and value of returning personal results from whole-genome sequencing when implemented on a larger scale remains to be seen.European Journal of Human Genetics advance online publication, 4 January 2017; doi:10.1038/ejhg.2016.178.",
author = "Sanderson, {Saskia C.} and Linderman, {Michael D.} and Suckiel, {Sabrina A.} and Randi Zinberg and Wasserstein, {Melissa P.} and Andrew Kasarskis and Diaz, {George A.} and Schadt, {Eric E.}",
year = "2017",
month = "1",
day = "4",
doi = "10.1038/ejhg.2016.178",
language = "English (US)",
journal = "European Journal of Human Genetics",
issn = "1018-4813",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Psychological and behavioural impact of returning personal results from whole-genome sequencing

T2 - the HealthSeq project

AU - Sanderson, Saskia C.

AU - Linderman, Michael D.

AU - Suckiel, Sabrina A.

AU - Zinberg, Randi

AU - Wasserstein, Melissa P.

AU - Kasarskis, Andrew

AU - Diaz, George A.

AU - Schadt, Eric E.

PY - 2017/1/4

Y1 - 2017/1/4

N2 - Providing ostensibly healthy individuals with personal results from whole-genome sequencing could lead to improved health and well-being via enhanced disease risk prediction, prevention, and diagnosis, but also poses practical and ethical challenges. Understanding how individuals react psychologically and behaviourally will be key in assessing the potential utility of personal whole-genome sequencing. We conducted an exploratory longitudinal cohort study in which quantitative surveys and in-depth qualitative interviews were conducted before and after personal results were returned to individuals who underwent whole-genome sequencing. The participants were offered a range of interpreted results, including Alzheimer’s disease, type 2 diabetes, pharmacogenomics, rare disease-associated variants, and ancestry. They were also offered their raw data. Of the 35 participants at baseline, 29 (82.9%) completed the 6-month follow-up. In the quantitative surveys, test-related distress was low, although it was higher at 1-week than 6-month follow-up (Z=2.68, P=0.007). In the 6-month qualitative interviews, most participants felt happy or relieved about their results. A few were concerned, particularly about rare disease-associated variants and Alzheimer’s disease results. Two of the 29 participants had sought clinical follow-up as a direct or indirect consequence of rare disease-associated variants results. Several had mentioned their results to their doctors. Some participants felt having their raw data might be medically useful to them in the future. The majority reported positive reactions to having their genomes sequenced, but there were notable exceptions to this. The impact and value of returning personal results from whole-genome sequencing when implemented on a larger scale remains to be seen.European Journal of Human Genetics advance online publication, 4 January 2017; doi:10.1038/ejhg.2016.178.

AB - Providing ostensibly healthy individuals with personal results from whole-genome sequencing could lead to improved health and well-being via enhanced disease risk prediction, prevention, and diagnosis, but also poses practical and ethical challenges. Understanding how individuals react psychologically and behaviourally will be key in assessing the potential utility of personal whole-genome sequencing. We conducted an exploratory longitudinal cohort study in which quantitative surveys and in-depth qualitative interviews were conducted before and after personal results were returned to individuals who underwent whole-genome sequencing. The participants were offered a range of interpreted results, including Alzheimer’s disease, type 2 diabetes, pharmacogenomics, rare disease-associated variants, and ancestry. They were also offered their raw data. Of the 35 participants at baseline, 29 (82.9%) completed the 6-month follow-up. In the quantitative surveys, test-related distress was low, although it was higher at 1-week than 6-month follow-up (Z=2.68, P=0.007). In the 6-month qualitative interviews, most participants felt happy or relieved about their results. A few were concerned, particularly about rare disease-associated variants and Alzheimer’s disease results. Two of the 29 participants had sought clinical follow-up as a direct or indirect consequence of rare disease-associated variants results. Several had mentioned their results to their doctors. Some participants felt having their raw data might be medically useful to them in the future. The majority reported positive reactions to having their genomes sequenced, but there were notable exceptions to this. The impact and value of returning personal results from whole-genome sequencing when implemented on a larger scale remains to be seen.European Journal of Human Genetics advance online publication, 4 January 2017; doi:10.1038/ejhg.2016.178.

UR - http://www.scopus.com/inward/record.url?scp=85008385061&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85008385061&partnerID=8YFLogxK

U2 - 10.1038/ejhg.2016.178

DO - 10.1038/ejhg.2016.178

M3 - Article

C2 - 28051073

AN - SCOPUS:85008385061

JO - European Journal of Human Genetics

JF - European Journal of Human Genetics

SN - 1018-4813

ER -